首页> 外文期刊>ADHD Attention Deficit and Hyperactivity Disorders >A pilot study: differential effects of methylphenidate-OROS on working memory and attention functions in children with attention-deficit/hyperactivity disorder with and without behavioural comorbidities
【24h】

A pilot study: differential effects of methylphenidate-OROS on working memory and attention functions in children with attention-deficit/hyperactivity disorder with and without behavioural comorbidities

机译:一项初步研究:哌醋甲酯-OROS对有或无行为合并症的注意力缺陷/多动障碍儿童的工作记忆和注意力功能的差异影响

获取原文
获取原文并翻译 | 示例
           

摘要

To examine the effects of methylphenidate-OROS (MPH-OROS) on working memory (WM) and attention functions in children with attention-deficit hyperactivity disorder (ADHD), and to investigate whether there is a differential effect in ADHD children with (ADHD+) and without (ADHD−) behavioural comorbidities. Participants included a clinic referred sample of 12 stimulant naïve school-aged children with a diagnosis of combined ADHD according to the DSM-IV criteria (6 ADHD+, 6 ADHD−), and 11 healthy children. A neuropsychological protocol was applied at three different moments: before treatment, after one those of MPH-OROS, and after one month of MPH-OROS daily treatment. The protocol was simultaneously administered to the control group. Initial differences in attention parameters between naïve children with ADHD and the control group disappeared after the first dose of MPH-OROS. For WM, one month of daily treatment was necessary to achieve this pattern of results. Both ADHD groups (ADHD+ and ADHD−) showed these differences, but there was a greater improvement in (ADHD−). MPH-OROS had an immediate effect on attention deficits, but long-term treatment was needed to improve WM to the level of healthy subjects. The presence of comorbid behavioural conditions determined a less robust response in neuropsychological performance to stimulant treatment.
机译:研究哌醋甲酯-OROS(MPH-OROS)对注意力缺陷多动障碍(ADHD)儿童的工作记忆(WM)和注意力功能的影响,并调查在患有ADHD(ADHD +)的儿童中是否有差异作用没有(ADHD−)行为合并症。参加者包括根据DSM-IV标准(6位ADHD +,6位ADHD-)诊断为合并ADHD的12名兴奋性初学者学龄儿童的临床参考样本和11名健康儿童。在三个不同时刻应用了神经心理学方案:治疗前,MPH-OROS治疗后一个,MPH-OROS每日治疗一个月后。该方案同时施用于对照组。初次服用MPH-OROS的多动症儿童与对照组之间注意力参数的最初差异消失了。对于WM,要达到这种结果模式,必须每天治疗一个月。两个ADHD组(ADHD +和ADHD-)都显示了这些差异,但(ADHD-)的改善更大。 MPH-OROS对注意力缺乏症具有立竿见影的效果,但是需要长期治疗才能将WM提高到健康受试者的水平。共病行为条件的存在决定了神经心理对刺激治疗的反应较弱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号